Rare diseases
Expansion into new international biotech markets can be challenging. Unfamiliar regulations and licensing, coupled with language and cultural differences, can all be barriers to growth. If you’re considering venturing into Europe and beyond, our easy-to-follow guides, shaped by 30 years of expertise in the rare disease market, will assist you in navigating challenges and gaining a profound understanding of the complexities involved in launching orphan drugs into new markets. To learn more about how Sciensus can facilitate and support your Europan expansion, visit: Rare Diseases and Orphan Drugs
![](https://www.sciensus.com/wp-content/uploads/2024/07/Hero-image-09-copy-640x234.png)
News, Rare diseases
Sciensus partners with Sentynl Therapeutics
![Cancer white paper image](https://www.sciensus.com/wp-content/uploads/2024/01/White-paper-landing-page-image-640x233.png)
Thought Leadership, Rare diseases
Launching successful patient support programs for rare disease patients across Europe
![](https://www.sciensus.com/wp-content/uploads/2024/07/Webinar-pic-0624-640x360.png)
News, Rare diseases
Sciensus webinar with Fierce Biotech: Unlocking the European orphan drug market
![Cross roads with cars at night](https://www.sciensus.com/wp-content/uploads/2024/03/Road-Hero_4a-640x233.jpg)
Blog, Rare diseases
Orphan drugs: How to avoid costly stock losses in Europe
![fallback image](https://www.sciensus.com/wp-content/themes/sciensus/dist/assets/images/fallback.png)
Blog, Rare diseases
Compassionate use programs in Europe: all you need to know
![out-licensing](https://www.sciensus.com/wp-content/uploads/2024/02/Comp-1-0-00-34-20-640x360.jpg)
Blog, Rare diseases
Out-licensing vs partnering: Strategies for accessing Europe
![Mother and son](https://www.sciensus.com/wp-content/uploads/2023/10/Mother-and-son-640x233.jpg)
Blog, Rare diseases
Is data drought holding back your orphan drug?
![](https://www.sciensus.com/wp-content/uploads/2024/05/Comp-1-0-00-11-20-640x360.jpg)
Thought Leadership, Rare diseases
Market access for orphan drugs in Switzerland: a guide for Biotechs
![Workplace meeting](https://www.sciensus.com/wp-content/uploads/2023/10/Workplace-meeting-640x233.jpg)
Blog, Rare diseases
An introduction to PASS studies